Compugen Ltd (Israel) Profile

1,298
ILS 55  4.07%

Compugen Ltd Summary

Compugen Ltd (CGEN) is traded on Tel Aviv Stock Exchange in Israel and employs 101 people. The company currently falls under 'Small-Cap' category with current market capitalization of 761.87M. Compugen Ltd operates under Healthcare sector and is part of Biotechnology industry. The entity has 57.21M outstanding shares. COMPUGEN has accumulated about 45.67M in cash with (23.45M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.77.
Check Compugen Ltd Probability Of Bankruptcy

Compugen Ltd Target Price Odds Analysis

Odds Below 1298.0HorizonTargetOdds Above 1298.0
78.05%30 days 1,298 21.86%
Based on normal probability distribution, the odds of Compugen Ltd to move above current price in 30 days from now is about 21.86% (This Compugen Ltd probability density function shows the probability of Compugen Ltd Stock to fall within a particular range of prices over 30 days) .

Compugen Ltd Top Holders

Compugen Ltd Income Statement Over Time

Net Income    Revenues    

Compugen Ltd Key Fundamentals

Compugen Ltd Against Markets

Compugen Ltd Current Ratings

Compugen Ltd 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
8
Chance of
Financial Distress (0 to 100%)
30%
Equity ratings for Compugen Ltd are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Compugen Ltd., a therapeutic discovery company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel and Europe. The company was incorporated in 1993 and is headquartered in Holon, Israel. Compugen Ltd operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. more
NameCompugen Ltd
President CEO, DirectorAnat CohenDayagView All
Macroaxis Advice
InstrumentIsrael Stock View All
RegionMiddle East
Business AddressAzrieli Center
Foreign Associate  USA
ExchangeTel Aviv Stock Exchange
CIK Number0001119774
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.cgen.com
Phone972 3 765 8585
CurrencyILS - Israeli Shekel
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterDecember 31, 2018
Last Fiscal Year EndDecember 31, 2018

Compugen Ltd Directors

Compugen Ltd Corporate Directors

Joshua Shemer Independent External Director
Michal Preminger Director
Dov Hershberg Director
Check also Trending Equities. Please also try Pattern Recognition module to use different pattern recognition models to time the market across multiple global exchanges.
Search macroaxis.com